Cointime

Vial

company

About

Vial is a clinical trial infrastructure company delivering dramatically faster and more efficient trials.

  • 51 - 100

Highlights

Total Funding Amount
$101M
Funding Rounds
2
Investors
1
Investments
4

Details

Last Funding Type
Series B
Last Funding Money Raised
$67M
Industries
Biotechnology,Clinical Trials,Health Care,Medical
Founded date
Jan 1, 2020
Number Of Employee
51 - 100
Operating Status
Active

Vial was founded to execute on a mission to reimagine clinical trials by delivering faster and more efficient trials for sponsors. Vial’s powerful technology platform delivers faster, more efficient trials that are up to 50% cheaper.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$101M
Vial has raised a total of $101M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2022 Series B $67M 1 General Catalyst — Detail
Nov 30, 2022 Series A $34M 1 General Catalyst — Detail

Investments

Number of Investments
Number of Lead Investments
4
0
Vial has made 4 investments. Their most recent investment was on Sep 27, 2019, when Eight Sleep raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 27, 2019 Eight Sleep
Pre-seed — Consumer Electronics —
Oct 27, 2010 DataStax
Series A $2.70M Information Technology —
Oct 15, 2010 Uber
Angel $1.25M Logistics —
Aug 1, 2010 StorkBrokers.com
Pre-seed — Children —

Investors

Number of Lead Investors
Number of Investors
2
1
Vial is funded by 1 investors. General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst Yes Series B
Cointime
เนื้อหา
บริษัท